Zeneca Group plc (NYSE ticker ZEN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zeneca Group plc (NYSE ticker ZEN)

ZEN 77.48

0.0%

Nov 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DavesM who wrote (18)	6/23/1998 8:13:00 PM
From: DavesM	Read Replies (1) of 75

Zeneca Diagnostics test for cancer is now available in Europe biz.yahoo.com The test detects 7 common mutations of the K-Ras oncogene. Zen claims that these mutations are implicated in 25% of lung cancers, 50% of colon cancers, and 90% of pancreatic cancers.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next